Financhill
Buy
64

DOCS Quote, Financials, Valuation and Earnings

Last price:
$62.30
Seasonality move :
15.61%
Day range:
$62.36 - $65.53
52-week range:
$25.00 - $85.21
Dividend yield:
0%
P/E ratio:
56.99x
P/S ratio:
22.31x
P/B ratio:
10.98x
Volume:
1.9M
Avg. volume:
2M
1-year change:
131.13%
Market cap:
$11.9B
Revenue:
$570.4M
EPS (TTM):
$1.11

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DOCS
Doximity
$139.6M $0.31 10.18% 45.82% $62.44
AMWL
American Well
$63.9M -$1.11 2.37% -66.95% $10.33
FOXO
FOXO Technologies
-- -- -- -- --
GDRX
GoodRx Holdings
$205.7M $0.10 2.59% 395.5% $6.32
SPOK
Spok Holdings
$35M $0.24 3% 18.18% $20.00
TEM
Tempus AI
$296.8M -$0.24 78.98% -96.54% $66.70
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DOCS
Doximity
$63.26 $62.44 $11.9B 56.99x $0.00 0% 22.31x
AMWL
American Well
$8.63 $10.33 $136.4M -- $0.00 0% 0.50x
FOXO
FOXO Technologies
$0.17 -- $1.1M -- $0.00 0% 0.04x
GDRX
GoodRx Holdings
$4.87 $6.32 $1.7B 60.88x $0.00 0% 2.35x
SPOK
Spok Holdings
$18.13 $20.00 $373M 23.24x $0.31 6.9% 2.68x
TEM
Tempus AI
$58.41 $66.70 $10.1B -- $0.00 0% 10.64x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DOCS
Doximity
-- 2.143 -- 6.68x
AMWL
American Well
-- 3.291 -- 2.76x
FOXO
FOXO Technologies
38.2% 9.895 144.44% 0.09x
GDRX
GoodRx Holdings
42.86% 0.034 30.85% 4.58x
SPOK
Spok Holdings
-- 1.151 -- 0.99x
TEM
Tempus AI
71.06% 5.141 9.59% 1.43x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DOCS
Doximity
$123.8M $48.7M 22.82% 22.82% 35.2% $97M
AMWL
American Well
$35.3M -$30.4M -43.63% -43.63% -45.5% -$25.1M
FOXO
FOXO Technologies
$1.3M -$1.5M -214.25% -- 8.49% -$1.3M
GDRX
GoodRx Holdings
$189.6M $23.4M 2.31% 4.21% 13.46% -$12.5M
SPOK
Spok Holdings
$29.1M $6.1M 10.19% 10.19% 16.74% $1.5M
TEM
Tempus AI
$155.2M -$68.7M -218.36% -- -36.89% -$109M

Doximity vs. Competitors

  • Which has Higher Returns DOCS or AMWL?

    American Well has a net margin of 45.17% compared to Doximity's net margin of -27.99%. Doximity's return on equity of 22.82% beat American Well's return on equity of -43.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    89.54% $0.31 $1.1B
    AMWL
    American Well
    52.76% -$1.19 $305.8M
  • What do Analysts Say About DOCS or AMWL?

    Doximity has a consensus price target of $62.44, signalling downside risk potential of -1.29%. On the other hand American Well has an analysts' consensus of $10.33 which suggests that it could grow by 19.74%. Given that American Well has higher upside potential than Doximity, analysts believe American Well is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    6 10 0
    AMWL
    American Well
    1 7 0
  • Is DOCS or AMWL More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison American Well has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DOCS or AMWL?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. American Well offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. American Well pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or AMWL?

    Doximity quarterly revenues are $138.3M, which are larger than American Well quarterly revenues of $66.8M. Doximity's net income of $62.5M is higher than American Well's net income of -$18.7M. Notably, Doximity's price-to-earnings ratio is 56.99x while American Well's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.31x versus 0.50x for American Well. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.31x 56.99x $138.3M $62.5M
    AMWL
    American Well
    0.50x -- $66.8M -$18.7M
  • Which has Higher Returns DOCS or FOXO?

    FOXO Technologies has a net margin of 45.17% compared to Doximity's net margin of -19.45%. Doximity's return on equity of 22.82% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    89.54% $0.31 $1.1B
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
  • What do Analysts Say About DOCS or FOXO?

    Doximity has a consensus price target of $62.44, signalling downside risk potential of -1.29%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Doximity has higher upside potential than FOXO Technologies, analysts believe Doximity is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    6 10 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is DOCS or FOXO More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DOCS or FOXO?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or FOXO?

    Doximity quarterly revenues are $138.3M, which are larger than FOXO Technologies quarterly revenues of $3.2M. Doximity's net income of $62.5M is higher than FOXO Technologies's net income of -$616.5K. Notably, Doximity's price-to-earnings ratio is 56.99x while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.31x versus 0.04x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.31x 56.99x $138.3M $62.5M
    FOXO
    FOXO Technologies
    0.04x -- $3.2M -$616.5K
  • Which has Higher Returns DOCS or GDRX?

    GoodRx Holdings has a net margin of 45.17% compared to Doximity's net margin of 5.45%. Doximity's return on equity of 22.82% beat GoodRx Holdings's return on equity of 4.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    89.54% $0.31 $1.1B
    GDRX
    GoodRx Holdings
    93.42% $0.03 $1.1B
  • What do Analysts Say About DOCS or GDRX?

    Doximity has a consensus price target of $62.44, signalling downside risk potential of -1.29%. On the other hand GoodRx Holdings has an analysts' consensus of $6.32 which suggests that it could grow by 29.71%. Given that GoodRx Holdings has higher upside potential than Doximity, analysts believe GoodRx Holdings is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    6 10 0
    GDRX
    GoodRx Holdings
    7 7 0
  • Is DOCS or GDRX More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DOCS or GDRX?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. GoodRx Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or GDRX?

    Doximity quarterly revenues are $138.3M, which are smaller than GoodRx Holdings quarterly revenues of $203M. Doximity's net income of $62.5M is higher than GoodRx Holdings's net income of $11.1M. Notably, Doximity's price-to-earnings ratio is 56.99x while GoodRx Holdings's PE ratio is 60.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.31x versus 2.35x for GoodRx Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.31x 56.99x $138.3M $62.5M
    GDRX
    GoodRx Holdings
    2.35x 60.88x $203M $11.1M
  • Which has Higher Returns DOCS or SPOK?

    Spok Holdings has a net margin of 45.17% compared to Doximity's net margin of 14.32%. Doximity's return on equity of 22.82% beat Spok Holdings's return on equity of 10.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    89.54% $0.31 $1.1B
    SPOK
    Spok Holdings
    80.13% $0.25 $151.7M
  • What do Analysts Say About DOCS or SPOK?

    Doximity has a consensus price target of $62.44, signalling downside risk potential of -1.29%. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 10.31%. Given that Spok Holdings has higher upside potential than Doximity, analysts believe Spok Holdings is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    6 10 0
    SPOK
    Spok Holdings
    1 0 0
  • Is DOCS or SPOK More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.582, suggesting its less volatile than the S&P 500 by 41.788%.

  • Which is a Better Dividend Stock DOCS or SPOK?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 6.9% to investors and pays a quarterly dividend of $0.31 per share. Doximity pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or SPOK?

    Doximity quarterly revenues are $138.3M, which are larger than Spok Holdings quarterly revenues of $36.3M. Doximity's net income of $62.5M is higher than Spok Holdings's net income of $5.2M. Notably, Doximity's price-to-earnings ratio is 56.99x while Spok Holdings's PE ratio is 23.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.31x versus 2.68x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.31x 56.99x $138.3M $62.5M
    SPOK
    Spok Holdings
    2.68x 23.24x $36.3M $5.2M
  • Which has Higher Returns DOCS or TEM?

    Tempus AI has a net margin of 45.17% compared to Doximity's net margin of -26.6%. Doximity's return on equity of 22.82% beat Tempus AI's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    89.54% $0.31 $1.1B
    TEM
    Tempus AI
    60.69% -$0.40 $1.1B
  • What do Analysts Say About DOCS or TEM?

    Doximity has a consensus price target of $62.44, signalling downside risk potential of -1.29%. On the other hand Tempus AI has an analysts' consensus of $66.70 which suggests that it could grow by 14.19%. Given that Tempus AI has higher upside potential than Doximity, analysts believe Tempus AI is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    6 10 0
    TEM
    Tempus AI
    4 6 0
  • Is DOCS or TEM More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tempus AI has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DOCS or TEM?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tempus AI offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. Tempus AI pays out -0.8% of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or TEM?

    Doximity quarterly revenues are $138.3M, which are smaller than Tempus AI quarterly revenues of $255.7M. Doximity's net income of $62.5M is higher than Tempus AI's net income of -$68M. Notably, Doximity's price-to-earnings ratio is 56.99x while Tempus AI's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.31x versus 10.64x for Tempus AI. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.31x 56.99x $138.3M $62.5M
    TEM
    Tempus AI
    10.64x -- $255.7M -$68M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Cisco Stock Be In 1 Year?
Where Will Cisco Stock Be In 1 Year?

Cisco Systems (NASDAQ: CSCO) rarely makes the front page of fintech…

Why Did David Tepper Sell Meta Stock?
Why Did David Tepper Sell Meta Stock?

Throughout 2024, David Tepper of Appaloosa Holdings sold more than…

The Market Tell Hiding in Plain Sight
The Market Tell Hiding in Plain Sight

Markets broadcast clues every day, but most traders tune in…

Stock Ideas

Buy
68
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 55x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
79
RYTM alert for Jul 10

Rhythm Pharmaceuticals [RYTM] is down 1.22% over the past day.

Sell
48
BGL alert for Jul 10

Blue Gold [BGL] is down 16.73% over the past day.

Buy
82
VRNA alert for Jul 10

Verona Pharma PLC [VRNA] is up 0.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock